Price
84.34
-2.64%52W Range
Market Cap
₹124.90 Cr
Traded: ₹0.07 Cr (0.05%) 0.0x
Free Float: ₹30.71 Cr (0.22% of FF traded)
Volume · 60D trend
7.93 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | -- | -5.0% | -- | +24.0% | Accelerating |
| ROE | -- | +13.0% | +7.0% | -- | -- | Decelerating |
| Return | -- | -7.0% | -32.0% | -20.0% | -- | Stable |
| Profit | -- | -- | -36.0% | -- | +50.0% | Accelerating |
Quarterly Results
Mar 2023
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 22 | 24 | 22 | 18 | 17 | 16 | 19 | 18 | 17 | 19 | 22 | 16 | 22 | 20 |
| Expenses | 19 | 20 | 19 | 16 | 15 | 14 | 17 | 15 | 15 | 16 | 17 | 14 | 18 | 15 |
| Operating Profit | 3 | 4 | 4 | 2 | 2 | 2 | 3 | 2 | 2 | 3 | 4 | 2 | 4 | 5 |
| OPM % | 12.3% | 17.2% | 16.0% | 10.1% | 9.9% | 13.4% | 13.8% | 13.3% | 12.0% | 14.1% | 20.1% | 14.8% | 17.3% | 25.5% |
| Other Income | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 1 | 3 | 2 | 0 | 0 | 1 | 2 | 2 | 2 | 2 | 4 | 2 | 3 | 4 |
| Tax % | 48.5% | 30.7% | 28.0% | 46.1% | -233.3% | 68.7% | 25.8% | 26.3% | 29.6% | 3.5% | 36.8% | 30.2% | 26.3% | 31.1% |
| Net Profit | 1 | 2 | 2 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 3 | 1 | 2 | 3 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 0.3 | 1.3 | 1.1 | 0.1 | 0.1 | 0.1 | 0.9 | 0.8 | 0.8 | 1.5 | 1.8 | 0.8 | 1.6 | 2.0 |
| Sales Growth (YoY) | 33.0% | 54.5% | 13.8% | -0.1% | -3.6% | -15.2% | -11.0% | 12.1% | -23.2% | -7.3% | -- | -- | -- | -- |
| Sales Growth (QoQ) | -9.6% | 9.8% | 24.6% | 7.6% | 5.0% | -19.1% | 9.3% | 3.8% | -7.7% | -15.0% | 37.7% | -28.9% | 11.4% | -- |
| OP Growth (YoY) | 65.6% | 98.1% | 31.2% | -24.2% | -20.9% | -19.5% | -38.6% | 0.9% | -46.6% | -48.7% | -- | -- | -- | -- |
| OP Growth (QoQ) | -35.4% | 18.4% | 97.2% | 9.8% | -22.7% | -21.6% | 14.0% | 14.6% | -21.4% | -40.2% | 87.2% | -39.4% | -24.5% | -- |
| Profit Growth (YoY) | 467.0% | 781.0% | 20.0% | -82.0% | -93.0% | -90.0% | -50.0% | -7.0% | -47.0% | -24.0% | -- | -- | -- | -- |
| EPS Growth (YoY) | 466.7% | 792.9% | 20.2% | -82.0% | -92.9% | -90.6% | -50.6% | -7.1% | -46.5% | -24.4% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -72.8% | 16.8% | 664.3% | 133.3% | -57.1% | -84.3% | 14.1% | -7.1% | -43.6% | -17.2% | 114.3% | -46.5% | -20.3% | -- |
| OP Margin | 12.3% | 17.2% | 16.0% | 10.1% | 9.9% | 13.4% | 13.8% | 13.3% | 12.0% | 14.1% | 20.1% | 14.8% | 17.3% | 25.5% |
| Net Margin | 2.3% | 7.6% | 7.2% | 1.2% | 0.6% | 1.3% | 6.8% | 6.5% | 7.3% | 11.9% | 12.2% | 7.8% | 10.4% | 14.6% |
| Material Cost % | 45.7% | 38.1% | 34.1% | 43.9% | 48.4% | 30.7% | 41.7% | 39.6% | 43.6% | 34.6% | 43.2% | 36.2% | 42.9% | 37.5% |
| Employee Cost % | 12.3% | 10.8% | 11.8% | 12.7% | 12.9% | 14.1% | 11.2% | 11.9% | 12.0% | 10.8% | 9.4% | 13.2% | 12.0% | 8.8% |
| P/S | 1.45 | 1.85 | 1.91 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 30.12 | 40.00 | 65.95 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 1.63 | 1.94 | 1.84 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Newspaper Publication - 30th AGM Notice and other related matters thereto.
Calendar of events for 30th AGM to be held on 17th September 2026 at 2:00 p.m. (IST) through VC/OAVM
Record Date for Final Dividend - 10th September 2026
Notice of 30th AGM to be held on Thursday, 17th September 2026 at 2:00 p.m. (IST) through VC/OAVM.
Annual Report for the F.Y. 2025-26
Unaudited Financial Results for the quarter ended 30th June 2026
The Board of Directors of the Company at their meeting held today i.e., Tuesday, 04th August 2026 at the Registered Office of the Company at 330, Trivia Complex, Natubhai Circle, Racecourse, ....
Updates on Acquisition - Incorporation of Chemcrux Foundation (Section 8 Company)
Certificate u/r 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June 2026
Intimation of Closure of Trading Window
Annual Secretarial Compliance Report for the year ended 31st March 2026
Newspaper Publication of Standalone and Consolidated Audited Financial Results for the quarter and year ended 31st March 2026.
The NRC has granted 107700 stock options to eligible employees pursuant to ESOP 2025/ Scheme. The grant date for ESOP Grant 1 - 2026 will be 15th May 2026.
Kalichem Private Limited (WOS) as part of its proposed diversification into inorganic chemical sector has filed CTE Amendment to GPCB for addition of various inorganic chemicals.
The Board at their meeting held today (14.05.2026) approved to incorporate a non-profit making company u/s 8 of the Companies Act, 2013 as the Wholly owned subsidiary of the Company; subject ....
Audited Financial Results for the quarter and year ended 31.03.2026
Recommendation of Final Dividend at rate of 10% (Re. 1/- per share) on the equity share of Rs. 10/- each subject to approval of members at ensuing AGM
Outcome of Board Meeting held on 14th May 2026. The Board approved: 1. Audited Standalone & Consolidated Financial Statements & Results for the Quarter and Year Ended 31st March 2026 2. ....
The meeting of Board of Directors is scheduled to be held on Thursday 14th May 2026 at 11:30 A.M. at Registered Office of the Company to consider the recommendation of Final Dividend, if ....
Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve 1. Audited Financial Statements ....
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Reply and Clarification on Price Movement sought by BSE Limited: E-mail dated 17th April 2026
The Exchange has sought clarification from Chemcrux Enterprises Ltd on April 17, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Certificate u/r 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st March 2026
Intimation of Closure of Trading Window
Receipt of in-principle approval from BSE Limited for 20,00,000 Equity Shares of Rs. 10/- each to be issued under "Chemcrux Enterprises Employee Stock Option Scheme 2025"
Newspaper Publication of Unaudited Financial Results for the quarter and nine months ended 31st December 2025
Unaudited Financial Results for the quarter and nine months ended 31st December 2025
The Board of Directors considered and approved Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2025 for F.Y. 2025-26 as reviewed ....
Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 ,inter alia, to consider and approve 1. Unaudited Financial ....
Certificate u/r 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st December 2025
Intimation of Closure of trading Window
Newspaper Publication - Unaudited Financial Results for the quarter and half year ended 30.09.2025
Appointment of Ms. Mruga Gajjar as Chief Financial Officer (KMP) of the Company w.e.f. 06th November 2025.
Unaudited Financial Results for the quarter and half year ended 30th September 2025
Board of Directors of the Company at their meeting held today i.e., Thursday, 06th November 2025 considered and approved following: 1. The Unaudited Standalone & Consolidated Financial ....
Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 ,inter alia, to consider and approve 1. Unaudited Financial ....
Certificate u/r 74(5) of SEBI (DP) Regulations, 2015 for the quarter ended 30th September 2025.
Receipt of Revocation of Closure Direction by GPCB
Intimation - Closure of Trading Window
At 29th AGM, shareholders have approved continuation of term of appointment of following Directors: 1. Mr. Girishkumar Shah (DIN: 00469291) 2. Mr. Sanjay Marathe (DIN: 01316388) 3. Mr. ....
At 29th AGM, shareholders have approved: 1. Appointment of Secretarial Auditor for 5 years 2. Chemcrux Enterprises Employee Stock Option Scheme (ESOP 2025/ Scheme)
At 29th AGM, shareholders have approved Increase in Authorised Share Capital and consequent amendment to MOA (in Capital Clause)
Submission of E-Voting Results and Scrutinizer''s Report for 29th AGM held on 24th September 2025
Summary of proceedings of 29th AGM held today i.e., Wednesday, 24th September 2025 at 11:00 A.M. (IST) through VC/OAVM is enclosed pursuant to Reg. 30 of SEBI (LODR) Regulations, 2015.
Issue of Closure Direction by Gujarat Pollution Control Board ("GPCB/Board")
Communication for TDS on Dividend for F.Y. 2024-25
Newspaper Publication of 29th AGM Notice
Web-link of Annual Report and AGM Notice for F.Y. 2024-25
Calendar of Events for 29th AGM to be held on 24th September 2025 at 11:00 A.M. through VC/OAVM